These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 4562425)

  • 1. The immune recognition of TA3 tumors, its facilitation by endotoxin, and abrogation by ascites fluid.
    Grohsman J; Nowotny A
    J Immunol; 1972 Nov; 109(5):1090-5. PubMed ID: 4562425
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.
    Fioretti MC; Libarati M; Bonmassar E; Cudkowicz G
    Cancer Res; 1975 Jan; 35(1):30-6. PubMed ID: 1089042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of chimerism in maintaining tolerance of skin allografts in mice.
    Lubaroff DM; Silvers WK
    J Immunol; 1973 Jul; 111(1):65-71. PubMed ID: 4576586
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF; Snell GD
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunity to a TA3 tumor subline that grows in allogeneic hosts elicited by strain-specific TA3 tumor cells.
    Lippman MM; Venditti JM; Kline I; Elam DL
    Cancer Res; 1973 Apr; 33(4):679-84. PubMed ID: 4696468
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms and kinetics of cyclophosphamide-induced specific tolerance to skin allografts in mice.
    Nirmul G; Severin C; Taub RN
    Transplant Proc; 1973 Mar; 5(1):675-8. PubMed ID: 4572127
    [No Abstract]   [Full Text] [Related]  

  • 9. Site dependency of TA3 Ha allotransplantability.
    Hagmar B; Ryd W
    Transplantation; 1977 Jan; 23(1):93-7. PubMed ID: 835167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 11. Escape of TA3 tumors from allogeneic immune rejection: theory and experiments.
    Nowotny A; Grohsman J; Abdelnoor A; Rote N; Yang C; Waltersdorff R
    Eur J Immunol; 1974 Feb; 4(2):73-8. PubMed ID: 4368695
    [No Abstract]   [Full Text] [Related]  

  • 12. Harding-Passey melanoma in the BALB-C mouse as a model for studying the interactions between host macrophages and tumor cells.
    Lejeune FJ
    Yale J Biol Med; 1973 Dec; 46(5):368-83. PubMed ID: 4205114
    [No Abstract]   [Full Text] [Related]  

  • 13. Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice.
    Vaage J
    Cancer Res; 1973 Aug; 33(8):1957-65. PubMed ID: 4720805
    [No Abstract]   [Full Text] [Related]  

  • 14. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on skin allograft reaction in closed colony black hairy mice previously implanted with selected malignant tumors.
    Uchiyama M
    Yokohama Med Bull; 1971 Oct; 22(3):49-71. PubMed ID: 4946489
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolation of pure IgG subclasses from mouse alloantiserum and their activity in enhancement and hyperacute rejection of skin allografts.
    Jansen JL; Gerard AP; Kamp J; Tamboer WP; Wijdeveld PG
    J Immunol; 1975 Aug; 115(2):387-91. PubMed ID: 807636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct evidence for rejection of tumour allografts in Str. pyogenes toxins-treated mice correlated with antistreptolysine O level in serum.
    Mikolásek J
    Neoplasma; 1972; 19(5):507-18. PubMed ID: 4118595
    [No Abstract]   [Full Text] [Related]  

  • 18. Colony-forming cells in irradiated, partially shielded, endotoxin-treated mice.
    Gidáli J; Fehér I; Gallyas A; Várterész V
    Radiat Res; 1969 Aug; 39(2):305-16. PubMed ID: 4894588
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of Escherichia coli endotoxin on skin allografts in mice.
    Skopińska E; Oluwasanmi JO
    Folia Biol (Praha); 1972; 18(4):270-6. PubMed ID: 4559930
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of tolerance with antilymphocytic serum.
    Lance EM; Medawar PB
    Transplant Proc; 1969 Mar; 1(1):429-32. PubMed ID: 4944254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.